Big Move For Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ) soared at $3.58, a gain of 54.3%. On Thu, Jan 19, 2023, SLRX:NASDAQ hit a New 2-Week High of $3.58. The stock got featured on our News Catalysts scanner on Thu, Jan 19, 2023 at 08:46 AM in the 'BIOTECH' category. From Thu, Jan 05, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days

About Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ)

Flex Pharma Inc is a US-based biotechnology company which is engaged in the developing proprietary treatments for muscle cramps and spasms associated with severe neurological conditions and exercise-associated muscle cramps. The lead drug product candidate is FLX-787 which is a single molecule, chemically synthesized, TRP ion channel activator and HOTSHOT, which is developed to prevent and treat exercise-associated muscle cramps. It operates through two segments - Consumer Operations and Drug Development. The Consumer Operations segment includes the development of HOTSHOT whereas the Drug Development segment includes the development of proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions.